Q4 2023 Evoke Pharma Inc Earnings Call Transcript
Good afternoon and welcome to the Evoke Pharma fourth-quarter and full-year 2023 earnings conference call. (Operator Instructions) I will now turn the call over to Daniel Kontoh-Boateng. Please go ahead, sir.
Good afternoon, and thank you for participating in the Evoke Pharma's conference call and webcast today. With me today are Dave Gonyer, Evoke's Chief Executive Officer, Chris Quesenberry, GIMOTI's Chief Commercial Officer from Eversana; and Matt DâOnofrio, Evoke's President and Chief Operating Officer.
By now, you should have a copy of the press release we issued earlier. If not, it is available on the Investor Relations page of our website at evokepharma.com. We encourage everyone to read today's press release, as well as in both annual report on Form 10-K, which is now filed with the SEC. The company's Form 10-K and earnings release are also available on the Evoke's website.
Please note that certain information discussed on the call today is covered under the
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |